Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Future, Synthomer

(Sharecast News) - Analysts at Berenberg lowered their target price on multimedia company Future from 3,250.0p to 2,600.0p on Thursday but said the stock still remained "undervalued". Berenberg said its thesis on Future was unchanged after the group's full-year 2022 results came in as expected, with 2023 adjusted underlying earnings guidance in line with the analysts' expectations.

The German bank stated Future continued to "operationally outperform" peers due to its "superior platform" and position in the value chain - a trend it believes will continue in 2023.

"Nevertheless, we do not expect Future's share to move in the right direction with sentiment to be driven by macro-economic factors until this thesis begins to be proven at the H1 results in mid-2023," said Berenberg.

However, longer term, Berenberg continues to believe Future's platform to be "on the right side" of the structural evolution of the advertising landscape, and that its shares offered "good value" at 11.5% free cash flow yield and a 9.1x price-to-earnings ratio.

Berenberg, which reiterated its 'buy' rating on the stock, added that its primary reason for reducing its target price on the stock was due to a higher weighted average cost of capital and lower peer multiples.

Analysts at Canaccord Genuity lowered their target price on specialty chemicals company firm Synthomer from 350.0p to 250.0p on Thursday following the group's capital markets day.

Canaccord Genuity said Synthomer's capital markets day, subsequent covenant relaxation, and movements in commodities, particularly European gas and its consequences on demand, all suggested that the group was facing "a classic inventory drawdown period".

The Canadian bank stated that nitrile - the key driver of profitability in the 2019-22 period - now looked likely to have a further extension to its downturn, contrary to previous expectations, and was predicted to actually see a further decline in contribution in the 2023 trading year.

"Absent disposals, we now forecast debt ratios to be close to covenant levels in the middle of next year, before improving sharply in the second half of the year," said Canaccord, which reiterated its 'buy' rating on the stock.

"Given all this, and the obvious lack of certainty on margins coming out of the downturn, we are updating our forecasts and price target to reflect the weaker outlook. Critically, we do not expect a further equity raise, and as disposal proceeds come in we expect concern for such a raise to materially diminish."

Share this article

Related Sharecast Articles

Broker tips: Volution, Videndum
(Sharecast News) - Jefferies reiterated its 'buy' rating and 510.0p target price on Volution on Wednesday as it said the company's ability to drive margins higher, through both revenue mix and efficiency, is more than offsetting the challenging market backdrop to deliver ongoing earning upgrades.
Broker tips: Marlowe, Fevertree
(Sharecast News) - Analysts at Berenberg slightly lowered their target price on software and services firm Marlowe from 720.0p to 710.0p on Tuesday but said the group's divestment of certain Governance, Risk and Compliance software and service assets had left it with a "much cleaner and simpler-to-understand equity story".
Broker tips: JD Sports, NatWest
(Sharecast News) - Barclays downgraded JD Sports on Monday to 'equalweight' from 'overweight' and cut its price target for the stock to 140.0p from 165.0p after the retailer announced the acquisition of US rival Hibbett last week for $1.1bn.
Broker tips: NatWest, Pensionbee, Greggs
(Sharecast News) - Shore Capital reiterated its 'buy' rating on bank NatWest after a forecast-beating first quarter but said it sees the least amount of upside potential in the stock compared with the wider banking sector.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.